THE SHORT ANSWER
Does Medicaid Cover Foundayo?
Always Verify Coverage With Your State Medicaid Program
Medicaid coverage changes frequently. States can modify, add, or remove coverage at any time due to budget constraints or policy changes. Before assuming you have (or don't have) coverage, call your state Medicaid program directly to verify current Foundayo coverage status.
Coverage Varies Dramatically by State
Only about 13 state Medicaid programs cover weight loss medications like Foundayo. Most state Medicaid programs either don't cover anti-obesity medications at all, or are actively ending coverage due to budget constraints.[1]
Unlike commercial insurance or Medicare, Medicaid coverage for weight loss medications is entirely optional for states. Federal law doesn't require states to cover anti-obesity drugs, which means:
- Only about 25% of states (approximately 13) cover GLP-1 (weight loss) medications[1]
- Coverage is shrinking—several states ended or restricted coverage in January 2026[2]
- Even in states with coverage, strict prior authorization requirements apply—your doctor must get approval before the medication is covered[3]
- Type 2 diabetes coverage is different—GLP-1 medications for diabetes are typically covered in all states
Bottom line: If you have Medicaid, your coverage depends entirely on your state's policies. Check with your state Medicaid program directly to confirm whether Foundayo is covered for weight loss.
For a complete overview of getting Foundayo covered regardless of insurer, see our full coverage guide.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
STATE-BY-STATE MEDICAID COVERAGE
Which States Cover Foundayo?
Based on the latest KFF Medicaid report and state policy documents, here's which states cover GLP-1s for obesity under their Medicaid programs. As Foundayo is newly FDA-approved (April 1, 2026), coverage decisions are still forming—states covering other GLP-1s may add Foundayo in the coming months.[1]
Coverage Is Changing Rapidly
State Medicaid coverage for weight loss drugs is in flux. Several states have recently ended or announced plans to end coverage. Always verify with your state Medicaid program before assuming coverage.
States With Medicaid GLP-1 Coverage (Foundayo May Be Included)
| State | Coverage Status | Key Details | Last Verified |
|---|---|---|---|
| Connecticut | Covered | Prior authorization required; BMI (body mass index) ≥30 or ≥27 with weight-related condition | April 2026 |
| Delaware | Covered | Prior authorization required; standard BMI criteria | April 2026 |
| Kansas | Covered | PA required; quantity limits may apply | April 2026 |
| Massachusetts | Covered | GLP-1s covered; may prefer certain products[4] | April 2026 |
| Minnesota | Covered | PA required; step therapy may apply | April 2026 |
| Mississippi | Covered | PA required; progress milestones for renewal[1] | April 2026 |
| New York | Covered | PA required; step therapy may apply | April 2026 |
| North Carolina | Reinstated Dec 2025 | Coverage reinstated December 12, 2025 per Governor's directive[5] | April 2026 |
| Vermont | Covered | PA required; standard BMI requirements | April 2026 |
| Wisconsin | Covered | PA required; BMI and documentation criteria | April 2026 |
States That Ended or Restricted Coverage (2026)
| State | Status | Notes | Effective Date |
|---|---|---|---|
| California (Medi-Cal) | Ended | Weight loss coverage ended; continues for diabetes, cardiovascular, MASH (fatty liver disease)[6] | Jan 1, 2026 |
| Pennsylvania | Ended (Adults 21+) | Adult weight loss coverage ended; under-21 and diabetes still covered[7] | Jan 1, 2026 |
| Michigan | Restricted | Now requires severe obesity + failure of all interventions + to avoid weight loss surgery[8] | Jan 1, 2026 |
| New Hampshire | Ended | No coverage for weight loss-only prescriptions[9] | Jan 1, 2026 |
States With Partial or Restricted Coverage
| State | Status | Notes |
|---|---|---|
| Texas | Partial | Restricted coverage; details vary by managed care plan |
| Washington | Partial | May cover for select populations; PA required |
| Arizona | Partial | Coverage varies by managed care plan; check your specific plan |
Note: As Foundayo is newly approved (April 1, 2026), specific coverage decisions are still forming. States covering other GLP-1s may or may not immediately add Foundayo to their preferred drug lists. Always verify directly with your state Medicaid program.
How to Check Your State's Coverage
Call Script for Medicaid
"Hi, I'm calling to check prescription drug coverage under my Medicaid plan. My member ID is [NUMBER]. I need to know:
- Is Foundayo (orforglipron) covered for chronic weight management?
- If not yet, when might coverage decisions be finalized for new medications?
- What are the prior authorization requirements?
- What BMI and documentation do I need?
- Is there step therapy—do I need to try other medications first?
- Can you send me the coverage criteria in writing?"
2026 MEDICAID CHANGES
States That Ended Coverage
Due to budget pressures and the high cost of GLP-1 medications (approximately $1,000/month at list price), several states have ended or restricted Medicaid coverage for weight loss drugs:
California (Medi-Cal) Ended Coverage January 1, 2026
As of January 1, 2026, Medi-Cal no longer covers GLP-1 medications for weight loss. All prior authorizations for weight loss ended December 31, 2025.[6]
Coverage continues with prior authorization for:
- Type 2 diabetes (Ozempic, Mounjaro, Rybelsus, Victoza, others)
- Cardiovascular disease (Wegovy)
- MASH/fatty liver disease (Wegovy)
- Members under 21 (federal law requires states to cover medically necessary treatments for children)
If you're affected: Talk to your doctor about diagnosis codes that may maintain coverage, or see our cost-help guide (note: Lilly Cares doesn’t list Foundayo).
North Carolina Reinstated Coverage December 12, 2025
Good news: After briefly ending coverage on October 1, 2025, NC Medicaid reinstated GLP-1 weight management coverage on December 12, 2025 per the Governor's directive.[5]
The NC Medicaid Preferred Drug List includes a GLP-1 weight management class with clinical criteria for coverage.
Pennsylvania Ended Adult Coverage January 1, 2026
Pennsylvania Medicaid ended coverage for GLP-1s prescribed for weight loss for adults age 21+ effective January 1, 2026.[7]
Coverage continues for:
- Members under 21 (federal law requires states to cover medically necessary treatments for children)
- Adults with diabetes or cardiovascular conditions (with prior authorization)
Michigan Restricted Coverage January 1, 2026
Michigan Medicaid made GLP-1 coverage significantly more restrictive effective January 1, 2026, due to state budget law.[8]
New requirements include:
- Severe obesity diagnosis
- Failure of all other weight loss interventions
- Use must be to avoid weight loss surgery
Current prior authorizations will be honored for 6 months.
Why States Are Cutting Coverage
State Medicaid programs are facing unsustainable costs from GLP-1 medications:
- GLP-1 medications cost approximately $1,000/month at list price—multiplied across thousands of beneficiaries[10]
- Medicaid drug spending on GLP-1s has increased dramatically since 2020[1]
- Budget constraints force states to make difficult coverage decisions
- Unlike commercial insurance, states can't spread costs across a broader risk pool
The CMS BALANCE Model (below) may help states that cut coverage reconsider, but it is voluntary for states and no participating state has been confirmed.
VOLUNTARY FOR STATES
CMS BALANCE Model
BALANCE Model: A Voluntary Option for State Medicaid Programs
On December 23, 2025, CMS (the federal agency that runs Medicare and Medicaid) announced the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth)—a voluntary model for state Medicaid programs built on manufacturer-negotiated GLP-1 pricing. Status: Voluntary for states, which can join between May 2026 and January 1, 2027; no participating state has been confirmed.[11]
Key Dates for Medicaid
- January 8, 2026: Deadline for states to submit Notice of Intent to participate
- May 1, 2026 – January 1, 2027: Window for state Medicaid programs to start participating. No participating state has been confirmed.
Note: Medicare has its own separate program—the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027) covers Foundayo for $50 per monthly fill, with conditions. BALANCE in Medicare Part D: Delayed, with no new start date. See our Medicare guide for details.
What This Means for Foundayo
- No confirmed state yet: Foundayo (orforglipron) was named in CMS’s BALANCE announcement, but no state Medicaid program has been confirmed as a participant
- States can opt in voluntarily, starting between May 2026 and January 1, 2027
- States that cut coverage (like California) may reconsider with lower pricing in 2026-2027
- Program includes lifestyle intervention requirements alongside medication
Important: No participating state has been confirmed. States must voluntarily participate, and coverage decisions may not change until late 2026 or 2027.
MEDICAID CRITERIA FOR FOUNDAYO
Prior Authorization Requirements
In states that cover GLP-1s through Medicaid, prior authorization is almost always required. Medicaid PA requirements are often stricter than commercial insurance:
Typical Medicaid PA Criteria
| Requirement | Typical Medicaid | Notes |
|---|---|---|
| BMI Threshold | ≥30, or ≥27 with a weight-related condition | Some states require higher BMI (≥35) |
| Qualifying Conditions | High blood pressure, type 2 diabetes, high cholesterol, sleep apnea, heart disease | Must be documented in medical records |
| Lifestyle Documentation | 6+ months of diet/exercise attempts | Medicaid often enforces this more strictly than private insurance |
| Step Therapy | Often required | May need to try phentermine or other medications first |
| Progress Requirements | 5% weight loss for renewal | Some states require ongoing progress milestones |
| Initial Approval | 3-6 months typical | You may need to reapply for continued coverage |
Documentation Checklist
Before your doctor submits a Medicaid PA request, ensure these are documented:
Required Documentation
- Current height and weight (measured within the last 30 days)
- BMI calculation documented by your doctor
- Diagnosis of obesity or weight-related conditions—your doctor should have these on file
- 6+ months of diet and exercise efforts—notes from doctor visits, dietitian referrals, or documented programs
- Previous weight loss attempts—what you've tried and why it didn't work long-term
Documentation That Strengthens Your Case
- Weight history showing obesity over the past 2-3 years
- Records of past weight loss medications you've tried (and the results)
- Recent lab work—blood sugar (A1C), cholesterol panel
- Sleep study results if you've been tested for sleep apnea
- Notes about how your weight affects your daily life
- Any hospital or ER visits related to weight complications
For complete PA preparation guidance, see our Foundayo prior authorization guide.
ALTERNATIVE OPTIONS
If Your State Doesn't Cover Foundayo
If your state Medicaid program doesn't cover Foundayo for weight loss, you still have options:
Self-Pay via LillyDirect
LillyDirect offers Foundayo at $149–$299/month depending on dose—significantly less than the approximately $1,000 list price. This is available to anyone, including Medicaid patients.
| Dose | Monthly Price | Notes |
|---|---|---|
| 0.8 mg (starting dose) | $149 | Initial titration |
| 2.5 mg | $149 | Titration (temporary price through December 31, 2026) |
| 5.5 mg | $199 | Maintenance (temporary price through December 31, 2026) |
| 9 mg | $299 | Maintenance |
| 14.5 mg | $299 | $349 if refill >45 days |
| 17.2 mg (highest) | $299 | $349 if refill >45 days |
- No insurance required—pay directly through LillyDirect
- Free home delivery
- 45-Day Refill Rule: For 14.5mg and 17.2mg doses, refill within 45 days to keep $299 pricing (otherwise $349)
See our LillyDirect guide for details.
Lilly Cares Patient Assistance (Not for Foundayo)
Zepbound, Mounjaro and Foundayo are not on Lilly Cares’ medication list, so Lilly Cares is not a route to free Foundayo. Lilly Cares also serves only people who are uninsured or on Medicare, not people enrolled in Medicaid.
See our patient assistance guide for other ways to lower the cost.
Consider Other Covered Medications
Your Medicaid may cover other weight loss medications:
- Phentermine—widely covered, much lower cost
- Contrave—covered by some state Medicaid programs
- Qsymia—less commonly covered, but worth checking
Check for Other Qualifying Indications
If you have additional health conditions, coverage may be available:
- Type 2 diabetes: GLP-1 medications for diabetes (like Ozempic or Mounjaro) are typically covered by Medicaid
- Cardiovascular disease: Some states cover Wegovy for cardiovascular risk reduction
Important note: Foundayo (orforglipron) and Mounjaro (tirzepatide) are different medications—they have different active ingredients, mechanisms, and FDA approvals. If your doctor mentions switching, they're prescribing a different drug, not a different form of the same drug.
If Coverage Recently Ended
If you were previously on a GLP-1 and your state ended coverage, talk to your doctor about:
- Switching to a different weight loss medication that's still covered
- Whether other health conditions might still qualify for coverage
- Self-pay options through LillyDirect
MEDICAID FOUNDAYO COVERAGE
Frequently Asked Questions
It depends entirely on your state. Only about 13 state Medicaid programs currently cover GLP-1s for weight loss. Most states either don't cover anti-obesity medications at all, or have recently ended or restricted coverage due to budget constraints. Since Foundayo is newly FDA-approved (April 1, 2026), specific coverage decisions are still forming—states that cover other GLP-1s may or may not immediately add Foundayo.
As of April 2026, states with Medicaid GLP-1 coverage for weight loss include: Connecticut, Delaware, Kansas, Massachusetts, Minnesota, Mississippi, New York, North Carolina (reinstated December 2025), Vermont, and Wisconsin. Several states recently changed coverage: California ended coverage January 1, 2026, Pennsylvania ended adult (21+) coverage January 1, 2026, Michigan significantly restricted coverage January 1, 2026, and New Hampshire ended coverage January 1, 2026. Always call your state Medicaid program to verify current Foundayo coverage.
California's 2025-26 state budget eliminated Medi-Cal coverage for GLP-1 weight loss medications effective January 1, 2026. The decision was driven by budget constraints—these medications cost approximately $1,000/month per patient at list price, which became unsustainable for the state program. Coverage continues for type 2 diabetes, cardiovascular disease, and MASH with prior authorization. The CMS BALANCE Model (voluntary for states; no participating state has been confirmed) may lead California to reconsider in the future.
Typical requirements include: BMI of 30 or higher (or 27+ with a weight-related condition like high blood pressure, type 2 diabetes, or sleep apnea), 6+ months of documented diet and exercise efforts, and often step therapy (trying cheaper medications like phentermine first). Some states require ongoing weight loss (at least 5%) for continued coverage. Medicaid PA requirements are often stricter than commercial insurance—ask for your state's specific criteria in writing.
You have several options: (1) Consider LillyDirect self-pay at $149–$299/month depending on dose; (2) Ask your doctor about other covered weight loss medications like phentermine or Contrave; (3) If you have type 2 diabetes, GLP-1 medications for diabetes are typically covered by Medicaid. Note: Lilly Cares doesn’t list Foundayo, so it isn’t a route to free Foundayo.
Foundayo (orforglipron) is FDA-approved specifically for chronic weight management, not type 2 diabetes. For diabetes treatment, other GLP-1 medications like Ozempic (semaglutide) or Mounjaro (tirzepatide) are typically covered by Medicaid. Important: Foundayo and Mounjaro are different medications with different active ingredients—Foundayo is orforglipron (a non-peptide oral tablet), while Mounjaro is tirzepatide (a dual GLP-1/GIP injection).
Medicaid appeal processes vary by state. Medicaid health plan: appeal within 60 days of the denial notice; the plan decides within 30 days (72 hours if urgent); then you can ask for a state fair hearing (your state allows 90–120 days). Fee-for-service Medicaid: ask for a fair hearing within your state’s deadline (no more than 90 days). Request your denial letter in writing with the specific reason for denial. Gather documents that address that reason (doctor's letter explaining medical necessity, weight records, diet/exercise documentation). At a fair hearing you can present your case to a state hearing officer. Check your denial notice for your exact deadlines. See our appeals guide for detailed steps.
The BALANCE Model (announced December 23, 2025) is a voluntary CMS model for state Medicaid programs built on manufacturer-negotiated GLP-1 pricing. Status: Voluntary for states, which can join between May 2026 and January 1, 2027; no participating state has been confirmed. States had to submit a Notice of Intent by January 8, 2026. The program includes standardized coverage criteria and lifestyle intervention requirements. States that cut coverage (like California) may reconsider, but participation is voluntary and coverage changes won't happen immediately.
YOUR PATH FORWARD
What's Next
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
Foundayo Coverage: Other Insurance Options
Coverage varies significantly by program type. See our guides:
- Medicare — Covered for weight loss through the Medicare GLP-1 Bridge for $50 per monthly fill, with conditions
- Blue Cross Blue Shield — Coverage varies by plan
- Aetna — Most plans cover with prior authorization
- Cigna — Coverage varies; PA required
- UnitedHealthcare — Coverage varies by plan type
Other GLP-1 Medications on Medicaid
Medicaid coverage varies by state and medication. Compare your options:
References
- Kaiser Family Foundation. (2025). "Medicaid Coverage of and Spending on GLP-1s." Confirms approximately 13 state Medicaid programs cover GLP-1s for obesity. kff.org
- KFF Health News. (2025). "As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off." September 4, 2025. kffhealthnews.org
- National Association of Medicaid Directors (NAMD). (2025). "Optional Not Mandatory: NAMD's Recommendations on Anti-Obesity Medication Coverage." February 2025. medicaiddirectors.org
- Massachusetts MassHealth Drug List. (2026). GLP-1 coverage for chronic weight management. mass.gov
- NC Department of Health and Human Services. (2025). NC Medicaid GLP-1 coverage reinstated December 12, 2025 per Governor's directive. medicaid.ncdhhs.gov
- California Department of Health Care Services. (2026). "State Budget Updates: Medi-Cal Rx Coverage Changes." GLP-1 weight loss coverage ended January 1, 2026. medi-calrx.dhcs.ca.gov
- Pennsylvania Department of Human Services. (2026). Pennsylvania Medicaid ended adult (21+) GLP-1 coverage for weight loss effective January 1, 2026.
- Michigan Department of Health and Human Services. (2026). Michigan Medicaid GLP-1 coverage restricted January 1, 2026 due to state budget law.
- New Hampshire Department of Health and Human Services. (2026). New Hampshire Medicaid ended coverage for GLP-1s prescribed solely for weight loss effective January 1, 2026.
- SingleCare. (2026). "How Much Does Foundayo Cost?" GLP-1 medications cost approximately $1,000/month at list price. singlecare.com
- CMS. (December 23, 2025). "BALANCE Model: Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth." Voluntary model for state Medicaid agencies; states can start between May 2026 and January 1, 2027. cms.gov
- Eli Lilly. (April 1, 2026). "FDA approves Lilly's Foundayo (orforglipron)." FDA approval announcement. investor.lilly.com
- Lilly Cares Foundation. (2026). "Patient Assistance Program." Free medications for qualifying patients; Foundayo is not on Lilly Cares’ medication list. lillycares.com
Reviewed by Honest Care GLP-1 SpecialistsLast updated October 6, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.